Global pharmaceutical sales up 5 percent: IMS Health

Share this article:
Global pharmaceutical sales grew 5 percent in the 12 months to August in leading markets, IMS Health said this week.
Sales through retail pharmacies in 13 leading markets, which account for more than two-thirds of the world market, totaled $364 billion in the period.
The single largest drug class was cholesterol-lowering medicines, which sold $27.8 billion and showed a growth rate of 8.2 percent, a slight decrease, from the previous 12-month period.
Pfizer's Lipitor cholesterol pill remained the world's best-selling drug, with global sales of $11.2 billion, followed by Merck's Zocor, AstraZeneca's Nexium, Sanofi-Aventis and Bristol-Myers Squibb's Plavix, and GlaxoSmithKline's Advair/Seretide.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Genentech shift could prove costly for hospitals

Genentech will use specialty distributors rather than wholesalers, hospitals pharmacy directors have learned.

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies